Table 4.
Results of sensitivity analysis
| Estimated costs and utilities | ICER ($/QALY)* | |||||
| -50% | Baseline | +50% | -50% | Baseline | +50% | |
| Costs ($) | ||||||
| Gargling (one time) | 0.2 | 0.4 | 0.6 | 5,000 | 31,800 | 58,600 |
| Physician consultation because of URTI | 8.6 | 17.2 | 25.9 | 33,900 | 31,800 | 29,600 |
| Medication to treat URTI | 0.6 | 1.2 | 1.8 | 31,900 | 31,800 | 31,700 |
| Lost productivity due to severe URTI | 48.9 | 97.7 | 146.6 | 41,400 | 31,800 | 22,100 |
| Utility | ||||||
| Utility in moderate influenza | 0.32 | 0.63 | 0.95 | 21,000 | 31,800 | 64,800 |
| Utility in severe influenza | 0.12 | 0.24 | 0.36 | 29,900 | 31,800 | 33,900 |
ICER = incremental cost-effectiveness ratio.
*ICERs for each group are rounded to the nearest $100.